Explore life science companies operating throughout Greater London, from biotechnology startups to global pharmaceutical organisations.
Life science incubator and lab space near King's Cross
London BioScience Innovation Centre (LBIC) is a life science incubator and laboratory facility wholly owned by the Royal Veterinary College, based across multiple sites in and around London's King's Cross Knowledge Quarter. It provides flexible wet lab and office space to early-stage and scaling life science…
Multimodal engineered T-cell therapies for treatment-refractory solid cancers
Alceus Bio is a biotechnology company developing next-generation engineered T-cell therapies for solid tumours. Its platform uses generative AI and synthetic biology to design therapeutic proteins that patient-derived immune cells are programmed to express and deliver in situ, targeting intracellular disease drivers…
Photosynthesis-based microalgae cultivation for sustainable food ingredients
Arborea is a UK industrial biotechnology company developing a cultivation system for photosynthetic microorganisms including microalgae, diatoms and phytoplankton. The system uses sunlight and CO₂ as feedstocks to grow microscopic plants at scale, from which proteins, natural pigments and bioactive nutrients are…
CAR-T and bispecific antibody therapies for blood cancers
Hemogenyx Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted therapies for haematological malignancies and autoimmune diseases. Its lead asset, HG-CT-1, is a third-generation anti-FLT3 CAR-T cell therapy for relapsed and refractory acute myeloid leukaemia, currently in a Phase 1…
Recombinant proteins, antibodies and reagents for drug development
ACROBiosystems is a global supplier of recombinant proteins, antibodies, kits and GMP-grade reagents supporting biopharmaceutical research and development. Products are used across the drug development continuum, from target discovery and candidate screening through to CMC development and clinical production. The…
Breath-based volatile organic compound test for multi-cancer detection
SpiraCheck is a biotechnology company developing a non-invasive breath test for the early detection of gastrointestinal cancers. Patients exhale into a collection device; the sample is analysed in the laboratory by mass spectrometry to quantify volatile organic compounds, and a patented algorithm interprets the…
Allogeneic neutrophil cell therapy platform for solid tumours
LIfT BioSciences is a biotechnology company developing a first-in-class allogeneic neutrophil immunotherapy for the treatment of solid tumours. Its platform produces Immuno-Modulatory Alpha Neutrophils (IMANs) from donor haematopoietic or induced pluripotent stem cells using a proprietary enhancement process. IMANs…
AI platform designing vaccines against current and future pathogens
Baseimmune is a biotechnology company developing a deep learning platform for computational vaccine antigen design. The platform integrates genomic, epidemiological, immunological, and evolutionary data to generate novel synthetic antigens drawn from across an entire pathogen genome, enabling the design of vaccines…
Precision medicine platform matching cancer patients to optimal therapies
Pathway Bio is a precision oncology company developing a functional platform to predict treatment response in individual cancer patients. The platform combines multiomic tumour profiling, AI-driven modelling, and ex vivo microcancer technology to screen therapies against a biological avatar of the patient's own tumour…
Clinical-stage rare disease biotech acquiring deprioritised pharma assets
Mereo BioPharma is a clinical-stage biopharmaceutical company focused on developing treatments for rare diseases. Founded in 2015, its business model centres on acquiring clinical-stage programmes deprioritised by large pharmaceutical companies and advancing them through further development. Lead programmes include…
No-code digital experiment platform for life science R&D
Synthace provides cloud-based software that enables life science researchers to design, automate and analyse experiments without writing code. Its platform integrates with laboratory automation hardware, structures experimental data and applies design of experiments methodologies, with a primary focus on assay…
Small molecule protein degraders targeting oncology and CNS disease
Kesmalea Therapeutics is a biotechnology company developing oral small molecule therapeutics that modulate protein homeostasis through targeted protein degradation and stabilisation. The company's platform is designed to convert the potency of protein degrader approaches into orally bioavailable, CNS-penetrant small…
Bioanalytical and toxicology laboratory for pharmaceutical and clinical research
Analytical Services International is a GLP and GCP-compliant bioanalytical laboratory providing mass spectrometry-based services to pharmaceutical companies and contract research organisations. Services include assay development, small molecule clinical bioanalysis, pharmacokinetic sample analysis, and…
Pharmacovigilance consultancy for clinical and post-marketing drug safety
Drive Phase PV Limited is a UK pharmacovigilance consultancy providing drug safety and device-vigilance services across clinical development and post-marketing settings. Services include PV system design, safety database management, signal detection, risk management plans, QPPV provision, periodic safety reporting,…
In vivo immune cell reprogramming for autoimmune and inflammatory disease
Flip Therapeutics is a biotechnology company developing in vivo immune cell engineering therapies for chronic autoimmune and inflammatory diseases, including multiple sclerosis, type 1 diabetes and inflammatory bowel disease. The company reprograms pathogenic T cells into homeostatic, anti-inflammatory cells directly…
Phase 3 urcosimod therapy for neuropathic corneal pain
OKYO Pharma is a clinical-stage biopharmaceutical company developing topical therapies for neuropathic corneal pain and other ocular surface conditions. Its lead candidate, urcosimod (formerly OK-101), is a chemerin receptor agonist designed to modulate inflammation and corneal pain signalling. Phase 2a testing…
AI-driven drug discovery targeting intrinsically disordered proteins
Peptone is a translational biophysics company developing novel therapeutics against intrinsically disordered proteins (IDPs), a class of structurally dynamic proteins implicated in cancer, inflammation and metabolic disease. The company combines hydrogen-deuterium exchange mass spectrometry, high-performance…
Microalgae and microbial bioactives for soil regeneration
HyveGeo is an industrial biotechnology company developing biological systems to regenerate degraded soils and support sustainable agriculture. Its circular biorefinery concept combines microalgae cultivation, microbial inoculants, compost-derived bioactives and engineered biochar. These components are used to recover…
Molecular diagnostics, biomarker research and genomic analysis services
BioMarker Solutions is a diagnostics and research services company supporting biomarker discovery, validation and molecular testing. Its activities cover genomic analysis, oncology diagnostics, clinical trial support, digital pathology and laboratory information systems. The group offers NGSuite software for…
Engineered T-regulatory cell therapies for immune-mediated diseases
Quell Therapeutics is a clinical-stage UK biotech developing engineered T-regulatory (Treg) cell therapies for immune-mediated diseases, using its proprietary technology to engineer Tregs with enhanced persistence and potency. Its lead candidate QEL-001 is in the Phase 1/2 LIBERATE trial for liver transplant…